SEOM clinical guideline for the management of cutaneous melanoma (2020)
Clin. transl. oncol. (Print)
; 23(5): 948-960, mayo 2021. tab, ilus
Artigo
em Inglês
| IBECS
| ID: ibc-221235
Biblioteca responsável:
ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
Melanoma affects about 6000 patients a year in Spain. A group of medical oncologists from Spanish Society of Medical Oncology (SEOM) and Spanish Multidisciplinary Melanoma Group (GEM) has designed these guidelines to homogenize the management of these patients. The diagnosis must be histological and determination of BRAF status has to be performed in patients with stage ≥ III. Stage IIII resectable melanomas will be treated surgically. In patients with stage III melanoma, adjuvant treatment with immunotherapy or targeted therapy is also recommended. Patients with unresectable or metastatic melanoma will receive treatment with immunotherapy or targeted therapy, the optimal sequence of these treatments remains unclear. Brain metastases require a separate consideration, since, in addition to systemic treatment, they may require local treatment. Patients must be followed up closely to receive or change treatment as soon as their previous clinical condition changes, since multiple therapeutic options are available (AU)
Texto completo:
Disponível
Coleções:
Bases de dados nacionais
/
Espanha
Base de dados:
IBECS
Assunto principal:
Neoplasias Cutâneas
/
Melanoma
Limite:
Humanos
País/Região como assunto:
Europa
Idioma:
Inglês
Revista:
Clin. transl. oncol. (Print)
Ano de publicação:
2021
Tipo de documento:
Artigo
Instituição/País de afiliação:
Consorcio Hospital General Universitario de Valencia/Spain
/
Hospital Dexeus/Spain
/
Hospital Universitario Regional Virgen Victoria/Spain
/
Hospital Universitario Virgen Macarena/Spain
/
Hospital Vall dHebron Barcelona/Spain
/
Hospital de la Santa Creu i Sant Pau/Spain
/
ICO-Badalona/Spain
/
Instituto de Investigación Sanitaria Gregorio Marañón and CIBERONC/Spain
/
OSI Donostialdea-Onkologikoa/Spain